TerrAscend (TSNDF) Cash from Investing Activities (2021 - 2026)

TerrAscend (TSNDF) reported Cash from Investing Activities of -$1.2 million for Q1 2026, up 63.73% year-over-year from -$727402.6 in Q1 2025, and up 76.77% quarter-over-quarter from -$5.1 million in Q4 2025.

TerrAscend (TSNDF) Cash from Investing Activities (2021 - 2026) Analysis & Trends

TerrAscend (TSNDF) has 6 years of Cash from Investing Activities data on file, last reported at -$1.2 million in Q1 2026.

  • Cash from Investing Activities for Q1 2026 came in at -$1.2 million, up 63.73% year-over-year; the trailing twelve-month figure through Mar 2026 was -$15.6 million (down 29.02% YoY), and the FY2025 annual result was -$17.7 million, down 44.65% from the prior year.
  • Cash from Investing Activities rose to -$1.2 million in Q1 2026 per TSNDF's latest filing, from -$5.1 million in the prior quarter.
  • Over five years, Cash from Investing Activities peaked at $14.3 million in Q1 2022 and troughed at -$15.4 million in Q4 2022.
  • A 5-year average of -$4.4 million and a median of -$3.4 million in 2024 frame the typical range for Cash from Investing Activities.
  • The sharpest annual moves came in 2022 and 2025: Cash from Investing Activities surged 210.94% in 2022, then slumped 451.69% in 2025.
  • A 5-year view of Cash from Investing Activities shows it stood at -$15.4 million in 2022, then soared by 80.99% to -$2.9 million in 2023, then plunged by 113.46% to -$6.2 million in 2024, then increased by 17.93% to -$5.1 million in 2025, then jumped by 76.77% to -$1.2 million in 2026.
  • Business Quant data shows TSNDF's Cash from Investing Activities at -$1.2 million in Q1 2026, -$5.1 million in Q4 2025, and -$1.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Investing Activities (Qtr)
1 Teva Pharmaceutical Industries 39.72 Bn 35.98 Bn 1.97 Bn 229.00 Mn
2 Zoetis 34.61 Bn 32.67 Bn 1.62 Bn -87.00 Mn
3 United Therapeutics 24.07 Bn 21.91 Bn 648.10 Mn 743.70 Mn
4 Aurora Cannabis 16.98 Bn 16.91 Bn 33.43 Mn -
5 Neurocrine Biosciences 16.64 Bn 15.32 Bn 800.70 Mn -506.20 Mn
6 Elanco Animal Health 12.19 Bn 11.76 Bn 785.00 Mn -60.00 Mn
7 Alkermes 7.37 Bn 6.86 Bn -116.06 Mn -2.08 Bn
8 Hims & Hers Health 6.62 Bn 5.87 Bn 396.79 Mn -15.45 Mn
9 Lantheus Holdings 6.47 Bn 5.97 Bn 230.92 Mn 25.99 Mn
10 TerrAscend - - 34.60 Mn -1.19 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.19 Mn
Mar 31, 2026 -1.19 Mn
Dec 31, 2025 -5.13 Mn
Dec 31, 2025 -5.13 Mn
Sep 30, 2025 -1.47 Mn
Sep 30, 2025 -1.47 Mn
Jun 30, 2025 -7.83 Mn
Jun 30, 2025 -7.83 Mn
Mar 31, 2025 -3.28 Mn
Mar 31, 2025 -3.28 Mn
Dec 31, 2024 -6.25 Mn
Dec 31, 2024 -6.25 Mn
Sep 30, 2024 -1.16 Mn
Sep 30, 2024 -1.16 Mn
Jun 30, 2024 -1.42 Mn
Jun 30, 2024 -1.42 Mn
Mar 31, 2024 -3.42 Mn
Mar 31, 2024 -3.42 Mn
Dec 31, 2023 -2.93 Mn
Dec 31, 2023 -2.93 Mn